NFE2L2 and head and neck squamous cell carcinoma: For expansion, we proteogenomically analyzed the CPTAC LUAD, LUSC, and HPV(−) HNSCC cohorts, which frequently contain NRF2 pathway–activating mutations (supplemental Fig. S2) (56, 57, 58).